Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ADPT
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Adaptive Biotechnologies Corp (ADPT) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ADPT trades at $21.02, down slightly by 0.19% today. The stock shows improving fundamentals with revenue growth from $179M in 2024 to $277M in 2025, though net losses persist. Technical indicators are bullish with strong moving average signals. Recent corporate actions include a 4:1 reverse stock split and plans to separate MRD and Immune Medicine businesses, potentially unlocking value. Analyst consensus is bullish with 11 buy ratings and a $20.80 price target.
ADPT presents a turnaround story with accelerating revenue growth and narrowing losses, though profitability remains elusive. The business separation could create focused entities with clearer valuation. Key risks include continued cash burn and execution challenges in the separation process. Upside potential exists if MRD business achieves sustained profitability as projected.
Read full analysis

Key Stats

  • Market Cap
    $3.43B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $22.90
  • 52W Low
    $10.24
  • Typical Hold Time
    -
  • Enterprise Value
    $3.29B
  • Div Yield
    -
  • Trading Activity
    -
$22.98
52W Low: $10.24
31 Jul 2025
52W High: $22.98
16 Jul 2026

Track Adaptive Biotechnologies Corp (ADPT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $10.24 and a high of $22.98, highlighting its annual price range. Buy and sell Adaptive Biotechnologies Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Most Recent News

Content is generated by Aura AI

US to impose 25% tariffs on most Brazilian imports starting July 22 amid trade disputes.

The US will impose a 25% tariff on most imports from Brazil starting July 22, following a yearlong investigation into alleged unfair trade practices by Brazil. The tariffs target issues such as Brazil's demands on US tech firms to remove political co...

Market News
4 hours ago
CNBC
Bearish
news icon
pluang ai news

Fundstrat's GRNJ ETF outperforms peers with AI-focused small/mid-cap stocks despite higher fees.

Fundstrat's Granny Shot US-Small & Mid-Cap ETF (GRNJ) has delivered strong year-to-date returns, beating similar ETFs like VOT and VOO despite its higher 0.75% expense ratio. The fund targets stocks at the intersection of major secular trends, partic...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
pluang ai news

Lockheed Martin Ventures opens London office to invest $100M in UK and Europe defense tech startups

Lockheed Martin Ventures, the $1 billion venture capital arm of Lockheed Martin, is expanding into the UK and Europe with a new London office. It plans to invest at least $100 million in defense technology startups to strengthen transatlantic defense...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $3.43B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $22.90
  • 52W Low
    $10.24
  • Typical Hold Time
    -
  • Enterprise Value
    $3.29B
  • Div Yield
    -
  • Trading Activity
    -
$22.98
52W Low: $10.24
31 Jul 2025
52W High: $22.98
16 Jul 2026

Track Adaptive Biotechnologies Corp (ADPT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $10.24 and a high of $22.98, highlighting its annual price range. Buy and sell Adaptive Biotechnologies Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!